NCT04726345View on ClinicalTrials.gov

Effect of Antihistamines on Ureteral Stent-Related Symptoms

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Nephrolithiasis
Interventions
DRUG

Fexofenadine Hcl 180Mg Tab

Fexofenadine 180mg tablet to be taken orally once a day until stent removal.

DRUG

Placebo

Placebo tablet to be taken orally once a day until stent removal.

Trial Locations (1)

10032

Columbia University Irving Medical Center/NYP, New York

Sponsors

Collaborators (1)

Coloplast A/S
All Listed Sponsors
collaborator

Coloplast A/S

INDUSTRY

lead

Columbia University

OTHER